Tokai Pharmaceuticals, Inc.;University of Washington;University of Maryland, Baltimore
发明人:
Vincent C. O. Njar,Amina Zoubeidi,Karen Ferrante,Eva Corey,Douglas B. Jacoby
申请号：
US14792490
公开号：
US09387216B2
申请日:
2015.07.06
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Described herein are methods and compositions for the treatment of prostate cancer in a subject in need thereof. The prostate cancer may be a castration resistant and an androgen receptor antagonist-resistant prostate cancer. The methods may comprise administering to the subject a CYP17-lyase inhibitor of Formula II.
